Search

Showing "11155" results for ""

HLA-B*5701 test for abacavir hypersensitivity works equally well in black and white patients

Start anti-HIV treatment with a CD4 cell count of 350 with efavirenz and Truvada, say draft British guidelines

GSK says its abacavir trials show no heart attack risk

8 million new HIV infections in Asia by 2020 unless prevention stepped up

Immune response in genital tract may explain why some exposed women not infected with HIV

More HIV-positive pregnant women getting antiretrovirals, but still much more to do, says report

Stress management therapy can improve quality-of-life for people with HIV

Anti-HIV treatment improves survival in patients with Hodgkin's lymphoma

Rapid selection of antimicrobial resistance by cotrimoxazole in HIV-infected Tanzanians

Oral candidiasis is a reliable marker of low CD4 counts and HIV disease progression in Zimbabwean women

British HIV Association treatment guidelines open for public comment

Patient groups campaign for better HIV/HCV treatment and care in southern Europe

Protease inhibitors increase fibrinogen levels: increased risk for hardening of the arteries

Electronic patient records have advantages for STI clinic

HIV prevention studies in Africa: it's important to ask about anal sex

Abacavir remains an equal first for people starting HIV treatment in US

Kaletra tablet for children gets EU marketing approval

Don't use azithromycin for gonorrhoea: six cases of high-level resistance in the UK

Receive the latest HIV research and conference news

Showing "11155" results for ""

HLA-B*5701 test for abacavir hypersensitivity works equally well in black and white patients

Start anti-HIV treatment with a CD4 cell count of 350 with efavirenz and Truvada, say draft British guidelines

GSK says its abacavir trials show no heart attack risk

8 million new HIV infections in Asia by 2020 unless prevention stepped up

Immune response in genital tract may explain why some exposed women not infected with HIV

More HIV-positive pregnant women getting antiretrovirals, but still much more to do, says report

Stress management therapy can improve quality-of-life for people with HIV

Anti-HIV treatment improves survival in patients with Hodgkin's lymphoma

Rapid selection of antimicrobial resistance by cotrimoxazole in HIV-infected Tanzanians

Oral candidiasis is a reliable marker of low CD4 counts and HIV disease progression in Zimbabwean women

British HIV Association treatment guidelines open for public comment

Patient groups campaign for better HIV/HCV treatment and care in southern Europe

Protease inhibitors increase fibrinogen levels: increased risk for hardening of the arteries

Electronic patient records have advantages for STI clinic

HIV prevention studies in Africa: it's important to ask about anal sex

Abacavir remains an equal first for people starting HIV treatment in US

Kaletra tablet for children gets EU marketing approval

Don't use azithromycin for gonorrhoea: six cases of high-level resistance in the UK

Receive the latest HIV research and conference news